<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04315649</url>
  </required_header>
  <id_info>
    <org_study_id>PhDLAJE2</org_study_id>
    <nct_id>NCT04315649</nct_id>
  </id_info>
  <brief_title>Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops</brief_title>
  <official_title>Effect of 3D Movie Viewing on Stereopsis in Strabismus and / or Anisometropic Amblyops</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Politècnica de Catalunya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Mutua de Terrassa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitat Politècnica de Catalunya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of 3D movie viewing on stereopsis recovery in anisometropic
      and / or strabismus amblyopia and the satisfaction with the intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Amblyopia is a visual neurodevelopmental disorder associated, more frequently, with the
      presence of strabismus and anisometropia. It is clinically most important visual condition in
      childhood because, apart from refractive error, it is the most frequent cause of vision loss
      in children. It is a reversible condition that affects up to 5% of the population, and that
      is the result of an abnormal visual experience during the most sensitive period of visual
      development. Although amblyopia is expressed in the clinical practice as a reduction in
      visual acuity, it is also characterized by an altered stereoscopy. Generally, treatments for
      amblyopia focus on the recovery of visual acuity, and there are no treatments that focus
      mainly on the recovery of the altered stereopsis, so present and with an important functional
      impact.

      The aim of this study reviewing, analyzing and, if applicable, updating the current treatment
      model for amblyopia. On the one hand, to evaluate the effectiveness of viewing a 3D movie in
      the improvement of stereoacuity and the deviation, as well as visual acuity and sensitivity
      to contrast. Also, the correlation between them. On the other hand, to assess quantitatively
      the degree of satisfaction and acceptance of the participants and their families towards the
      intervention.

      A quasi-experimental study will be performed, without a control group, pre- and post-
      intervention in which subjects with refractive and / or strabismus amblyopia, that have been
      subjected to traditional treatment for amblyopia, will be selected. Variables of stereopsis,
      latent or manifest deviation, visual acuity and sensitivity to the contrast will evaluate
      previously and after the intervention.

      The sample will include subjects between 5 to 12 years old with a diagnosis of refractive and
      / or strabismic amblyopia.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2020</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Stereopsis (ST with StereoTAB) at 2 weeks and 3 months studying the effect of viewing a 3D movie in the visual function.</measure>
    <time_frame>Baseline, 2 weeks and 3 months</time_frame>
    <description>Stereopsis (ST in logMAR) will be evaluated by a Multiple Random Points test through an Ipad. The app is StereoTAB and uses anaglyphic glasses. The measures will be performed at 50 cm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline Stereopsis (ST with Randot Dot Test) at 2 weeks and 3 months studying the effect of viewing a 3D movie in the visual function.</measure>
    <time_frame>Baseline, 2 weeks and 3 months</time_frame>
    <description>Stereopsis (ST in logMAR) will be evaluated by a Randot Dot Test. The measures will be performed at 40 cm.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline latent or manifest deviation at 2 weeks and 3 months studying the effect of viewing a 3D movie in the visual function.</measure>
    <time_frame>Baseline, 2 weeks and 3 months</time_frame>
    <description>Latent o manifest deviation will be evaluated in the two distances (40 cm and 6 m) and will be measured by prisms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction assessed by an ordinal questionnaire designed based on the Treatment Satisfaction Questionnaire for Medication (TSQM).</measure>
    <time_frame>2 weeks</time_frame>
    <description>Satisfaction assessed by an ordinal questionnaire (1 to 5, as 1 the lowest satisfaction and 5 the highest satisfaction), based on the TSQM (Treatment Satisfaction Questionnaire for Medication) version 1.4 to provide data regarding the degree of satisfaction and sensation of parents and children in relation to treatment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Amblyopia</condition>
  <condition>Anisometropic Amblyopia</condition>
  <condition>Strabismic Amblyopia</condition>
  <arm_group>
    <arm_group_label>3D movie</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3D movie viewing</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3D movie viewing</intervention_name>
    <description>3D movie viewing</description>
    <arm_group_label>3D movie</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of refractive and / or strabismus amblyopia at some point in life

          -  History of amblyopia treatment completed at least 6 months before the intervention

          -  Deviation angle equal to or less than 10 Dp

          -  Absence of associated ophthalmological pathology.

        Exclusion Criteria:

          -  Ongoing amblyopia treatment;

          -  Non-comitant and/or large constant strabismus (&gt;10 prism diopters)

          -  Any ocular pathological condition or nystagmus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Asensio Jurado, MsC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat Politècnica de Catalunya</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Argilés Sans, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universitat Politècnica de Catalunya</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lluïsa Quevedo i Junyent, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universitat Politècnica de Catalunya</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Asensio Jurado, MsC</last_name>
    <phone>0034636760450</phone>
    <email>asensiojlaura@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc Argilés Sans, PhD</last_name>
    <phone>00346636818571</phone>
    <email>marcargiles@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laura Asensio Jurado</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Bridgeman B. Restoring adult stereopsis: a vision researcher's personal experience. Optom Vis Sci. 2014 Jun;91(6):e135-9. doi: 10.1097/OPX.0000000000000272.</citation>
    <PMID>24811849</PMID>
  </reference>
  <reference>
    <citation>Levi DM, Knill DC, Bavelier D. Stereopsis and amblyopia: A mini-review. Vision Res. 2015 Sep;114:17-30. doi: 10.1016/j.visres.2015.01.002. Epub 2015 Jan 29. Review.</citation>
    <PMID>25637854</PMID>
  </reference>
  <reference>
    <citation>Li RW, Tran KD, Bui JK, Antonucci MM, Ngo CV, Levi DM. Improving Adult Amblyopic Vision with Stereoscopic 3-Dimensional Video Games. Ophthalmology. 2018 Oct;125(10):1660-1662. doi: 10.1016/j.ophtha.2018.04.025. Epub 2018 May 18.</citation>
    <PMID>29779684</PMID>
  </reference>
  <reference>
    <citation>Birch EE, Jost RM, De La Cruz A, Kelly KR, Beauchamp CL, Dao L, Stager D Jr, Leffler JN. Binocular amblyopia treatment with contrast-rebalanced movies. J AAPOS. 2019 Jun;23(3):160.e1-160.e5. doi: 10.1016/j.jaapos.2019.02.007. Epub 2019 May 16.</citation>
    <PMID>31103562</PMID>
  </reference>
  <reference>
    <citation>Bossi M, Tailor VK, Anderson EJ, Bex PJ, Greenwood JA, Dahlmann-Noor A, Dakin SC. Binocular Therapy for Childhood Amblyopia Improves Vision Without Breaking Interocular Suppression. Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3031-3043. doi: 10.1167/iovs.16-20913.</citation>
    <PMID>28614556</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>March 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2020</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>3D movies</keyword>
  <keyword>Amblyopia treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
    <mesh_term>Strabismus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

